New Delhi, Nov. 28 -- With the growing market for weight loss drug, the companies that manufacture Ozempic and Mounjaro are reportedly planning to launch a new weight loss drugs that could be gamechanger in the process.

The new medicine won't need a needle and can be 'taken once per day without food and water restrictions'.

Both Novo Nordisk and Eli Lilly have developed oral versions. Though the Food and Drug Administration has not yet given its approval, the first oral medicine could see green light soon.

According to NPR, the Novo Nordisk's obesity pill is expected to be approved first and it has the same ingredient - semaglutide - that's in Wegovy and Ozempic.

Ladbible reported that GLP-1 medicine is for adults with Type-2 diabetes...